Background: Statins elicit antioxidant effects independently of their lipid-lowering properties. Heme oxygenase-1 (HO-1) induction may be a part of these pleiotropic effects, which are insufficiently described in the kidney. We hypothesize that simvastatin (SIM) transcriptionally activates HO-1 that protects renal proximal tubule cells from lipotoxic injury. Methods: Impact of SIM on 100 μmol/l oleic acid (OA)-mediated reactive oxygen species (ROS) production and consequent oxidative stress (4-hydroxynonenal (HNE) content) as well as cell injury/apoptosis (lactate dehydrogenase (LDH) release, caspase-3 activation) were determined in cultured renal proximal tubule (NRK52E) cells. Effect of SIM on the HO-1 promoter and its enhancer elements (antioxidant response element (ARE), CCAAT, AP1, and cAMP response element (CRE)) was also determined in reporter luciferase assays. Dominant-negative (dnMEK, M1CREB) and pharmacologic (H89) approaches were used to inhibit activation of extracellular signal regulated kinase (ERK), CREB, and protein kinase A (PKA), respectively. results: SIM dose-dependently activated the HO-1 promoter that was essential for protection against OA-dependent ROS production/oxidative stress and LDH release/caspase-3 activation. We found that the HO-1 promoter was induced through ERK and PKA-dependent activation of the CRE by SIM. conclusion: SIM may protect the kidney from adverse effects of circulating fatty acids by upregulating the antioxidant HO-1, aside from its well-described lipid-lowering effects. o besity is a growing problem among patients of all ages (1,2) that has a variety of effects on different organs including the kidney (3). Adverse effects of obesity are due to increased vascular reactivity, inflammation, and other factors called lipotoxicity (3). Obesity is associated with an elevation of circulating free fatty acids that are responsible for increased oxidative stress and subsequent lipotoxicity (3). Oleic acid (OA), a free fatty acid, is present in high concentration in the plasma of obese individuals (4). Previously, we showed that OA increases production of reactive oxygen species (ROS) that induces oxidative injury in renal proximal tubule cells (5).
o besity is a growing problem among patients of all ages (1, 2) that has a variety of effects on different organs including the kidney (3) . Adverse effects of obesity are due to increased vascular reactivity, inflammation, and other factors called lipotoxicity (3) . Obesity is associated with an elevation of circulating free fatty acids that are responsible for increased oxidative stress and subsequent lipotoxicity (3) . Oleic acid (OA), a free fatty acid, is present in high concentration in the plasma of obese individuals (4) . Previously, we showed that OA increases production of reactive oxygen species (ROS) that induces oxidative injury in renal proximal tubule cells (5) .
Statins-such as simvastatin (SIM)-are extensively used to lower dyslipidemia in children (6) . Statins are not only lower lipids but also shown to exert "pleiotropic" effects that are not due to their lipid-lowering activity (7) . For example, SIM transcriptionally activates the antioxidant HO-1 gene in the liver and NIH3T3 cells (8, 9) . It is plausible that such antioxidant properties can be used to diminish lipotoxic oxidative stress, caused by obesity. HO-1 induction-dependent renoprotective effects of SIM in a rat model of acute ischemia/reperfusion injury are noted (10) but the underlying mechanism and its potential role in obesity is unknown.
Heme oxygenase-1 (HO-1) elicits adaptive responses against oxidative stress in the kidney (11) . Oxidative stress transcriptionally induces the HO-1 promoter mostly via the antioxidant response element (ARE) (12) . Studies have shown that HO-1 protects from obesity-associated oxidative stress (13) and hence, from lipotoxic injury. Some studies have also shown that SIM increases activity of the ARE and expression of HO-1 protein (8, 14) ; however, there is little data on renal cells.
Accordingly, we hypothesized that SIM protects renal proximal tubule cells from oleic acid-induced oxidative stress via transcriptional upregulation of HO-1.
RESULTS

SIM Dose-Dependently Induces the HO-1 Promoter but Also Increases Cytotoxicity in Renal Proximal Tubule Cells
First, we needed to determine whether SIM activates the HO-1 promoter and elicits any cytotoxicity. Accordingly, NRK52E cells were transfected with an HO-1-promoter luciferase reporter together with a renilla luciferase and were treated with SIM in doses of 0, 5, 10, 25, 50, and 100 μmol/l. Twenty-four hours later, luciferase activities were determined. As shown in Figure 1 , panel a, SIM dose-dependently induced the HO-1 promoter but at concentrations higher than 25 μmol/l also significantly increased lactate dehydrogenase (LDH) release (Figure 1, panel b) and ROS production (Figure 1, panel c) indicating toxicity. Hence, 10 μmol/l of SIM dose was chosen for further experiments, which is nontoxic but still significantly Next, we determined whether SIM exerts protective effect against OA-mediated lipotoxicity in renal proximal tubule cells? Accordingly, cells were left untreated or pretreated with 10 μmol/l SIM for overnight prior to treatment with 100 μmol/l OA: ROS production as well as the resultant oxidative stress was determined. Figure 2 , panel a shows, that OA greatly increases ROS production, which was significantly attenuated upon pretreatment with SIM. In addition, 4-hydroxynonenal (HNE) content (a product of lipid peroxidation) of OA-treated cells was also significantly increased (Figure 2, panel b) , which indicates increased oxidative stress in OA-treated cells. Importantly, SIM treatment attenuated both ROS production (Figure 2 , panel a) and oxidative stress (Figure 2, panel b) .
Previously, we demonstrated that OA-associated oxidative stress is responsible for cell injury in cultured renal proximal tubule cells (5) . Hence, we determined whether SIM mitigates OA-mediated cell injury? To verify this, cells were pretreated with 10 μmol/l SIM overnight prior to treatment with 100 μmol/l OA and LDH release was determined 24 h later. Figure 2 , panel c depicts that SIM significantly attenuated LDH release. We also verified that the observed lipotoxicity is-at least partly-due to apoptotic events, extent of which is quantified by measuring caspase3/7 activity (Figure 2, panel d) .
Next, we assessed whether protective effects of SIM are related to induction of HO-1. Accordingly, NRK52E cells were pretreated with 10 μmol/l SnPP (to inhibit HO-1 activity) 1 h prior to overnight treatment with 10 μmol/l SIM followed by 100 μmol/l OA. ROS production, intracellular HNE content, LDH release, and caspase 3/7 activation were determined as above. Next, we assessed whether ARE, which is a major enhancer in the HO-1 promoter (12), is activated by SIM. Accordingly, NRK52E cells were transfected with an ARE-luciferase reporter together with a renilla luciferase and treated with 10 μmol/l SIM. After 24 h, luciferase activities were determined. Figure 3 , panel a shows that-surprisingly-SIM does not activate the ARE even though it induces the HO-1 promoter ( Figure 1 , panel a). These results suggest that SIM may target other enhancer sites in the HO-1 promoter such as AP-1, CCAAT, or cAMP response element (CRE) (15) . Accordingly, NRK52E cells were cotransfected with either of those luciferase reporters plus a renilla luciferase and treated with 10 μmol/l SIM for 24 h. 
SIM Activates the CRE and Hence, HO-1, via ERK and PKA
The CRE binds the activated transcription factor CREB (cAMP response element binding protein) (16) . CREB activation occurs via phosphorylation by kinases such as extracellular signal regulated kinase (ERK) or protein kinase A (PKA) (16) . First, we determined whether SIM phosphorylates CREB in NRK52E cells, although reporter studies ( Figure 3 , panel b) indirectly imply it. Accordingly, cells were treated with 10 μmol/l SIM for 30 min; cell lysates were prepared and CREB phosphorylation was determined by western blotting. Figure 4 , panels a,b show that CREB phosphorylation is significant at that time point. In the next set of experiments, we determined whether inhibition of ERK phosphorylation (through dominant-negative inhibition of its upstream kinase MEK: dnMEK) or pharmacologic inhibition of PKA (by H89) affects SIM-dependent induction of the CRE reporter. Accordingly, NRK52E cells were transfected with CRE-luc and renilla plasmids together with a dnMEK plasmid or treated with 10 μmol/l H89 1 h prior to (a) NRK52 cells were treated with 100 μmol/l OA and ROS production was determined as described in Materials and Methods. In some experiments, cells were pretreated with 10 μmol/l SIM overnight prior to treatment with OA. To demonstrate the role of HO-1 in SIM-associated protection, 10 μmol/l SnPP (HO-1 activity inhibitor) was applied 30 min prior to treatment with 10 μmol/l SIM. ROS production was expressed as percentage of untreated. n = 3, *P < 0.05 compared to untreated or as indicated, **P < 0.05 compared to OA-treated. (b) Cells were treated similar to (a) and 4-hydroxynonenal (HNE) content of the cells were determined as described in Materials and Methods. HNE content was expressed as percentage of untreated. n = 3, *P < 0.05 compared to untreated or as indicated, **P < 0.05 compared to OA-treated. (c) Extent of cell injury was determined by means of lactate dehydrogenase (LDH) release as described in Materials and Methods. LDH release was expressed as percentage of untreated. n = 3, *P < 0.05 compared to untreated or as indicated, **P < 0.05 compared to OA-treated. (d) Presence and extent of apoptosis was determined by means of caspase 3/7 activation as described in Materials and Methods. Caspase 3/7 activation was expressed as percentage of untreated. n = 3, *P < 0.05 compared to untreated or as indicated, **P < 0.05 compared to OA-treated. Our results demonstrate that SIM induces the HO-1 promoter via ERK/PKA-dependent activation of the CRE enhancer. Since protective effects of SIM against lipotoxicity depend on HO-1 activation (Figure 2) , it should also depend on activation of ERK, PKA, and CREB/CRE. To prove this, NRK52E cells were transfected with either dnMEK (to inhibit ERK activation), M1CREB (to inhibit CREB) or treated with H89 (to inhibit PKA) prior to treatment with SIM+OA: ROS production, intracellular HNE content, LDH release, and caspase3/7 activation were determined. Figure 5 , panels a-d show that inhibition of ERK, PKA, or CREB significantly abrogated beneficial effects of SIM.
These results suggest that SIM protects from OA-mediated lipotoxicity via ERK/PKA-dependent activation of the CRE enhancer in the HO-1 promoter.
DISCUSSION
Obesity-linked dyslipidemia is associated with increased oxidative stress in the kidney (17, 18) . Conversely, treating dyslipidemia with statins preserves renal function (18, 19) . Interestingly, asides from their lipid lowering effects, statins also elicit antioxidant properties (10, 20) that may contribute to the observed renoprotection. It has been shown that statins exert "pleiotropic" properties that are independent from their lipid-lowering effects (7). For example, statins induce HO-1 in nonrenal tissues/cells (8, 9, (21) (22) (23) (24) at the level of transcription in vitro (9) and in vivo (20) . However, impact of statins on renal HO-1 is less known: Chen et al. (25) showed that SIM treatment increased renal expression of HO-1, while Gueler et al. (20) showed that cerivastatin increases HO-1 protein and mRNA in the kidney, which was associated with infiltrating macrophages and not renal cells. On the other hand, the mechanism by which SIM regulates renal HO-1 is virtually unknown. Some studies demonstrated that statins activate the ARE (8) or the C/EBP-binding element (CCAAT) (9,26) of the HO-1 promoter in nonrenal cells.
Using NRK52E renal proximal tubule cells, we found that SIM significantly augments activity of a HO-1-promoter luciferase reporter (Figure 1, panel a) and increases expression of HO-1 protein (Figure 1, panels d,e) . However, higher concentrations of SIM (above 25 μmol/l) elicited increasing cytotoxicity (Figure 1, panel b) probably through augmented ROS generation (Figure 1, panel c) . Further reporter luciferase studies revealed that SIM activates the CRE but not the ARE, CCAAT, or AP-1 (Figure 3, panel a) . Since the dominant-negative M1CREB inhibited SIM-dependent induction of the HO-1 promoter (Figure 3, panel b) , we postulated that the CRE is the target for SIM in the promoter proximal region of the HO-1 gene. The CRE element binds the phosphorylated CREB (cAMP response element binding protein) (16) and activates transcription of target genes (27) including the antioxidant HO-1 (12) . SIM increases phosphorylation of CREB in the brain (28) , in the heart (29), and in endothelial cells (30) while in renal cells or in the kidney is unknown. We discovered that SIM phosphorylates CREB in cultured renal proximal tubule cells (Figure 4, panels a,b) . Kinases that phosphorylate CREB include ERK and PKA (16) . Inhibitors of ERK (dnMEK) or PKA (H89) inhibited SIM-dependent activation of the CRE (Figure 4 , panel c) suggesting that both ERK and PKA are responsible for CREB/CRE activation.
SIM-dependent induction of HO-1 in the kidney (25), lung, and heart (24) of mice has been reported but there is no data available whether this HO-1 induction is CREBdependent. Our in vitro studies reveal that SIM activates the HO-1 promoter via ERK, PKA (Figure 4, panel d) , and CRE (Figure 3, panel b) . Further in vivo studies are needed to determine impact of SIM on the CREB/HO-1 system in the kidney. Nevertheless, to the best of our knowledge, for the first time HO-1) promoter via the cAMP response element (CRE). (a) NRK52E cells were cotransfected with an antioxidant response element, AP-1, CCAAT, or CRE luciferase plasmid together with renilla luciferase and treated with 10 μmol/l SIM. Twenty-four hours later luciferase activities were determined as described in Materials and Methods. n = 3, *P < 0.05 compared to untreated; M1CREB: mutant CREB (B) NRK52E cells were cotransfected with a HO-1 promoter and renilla luciferase plasmid with or without an M1CREB plasmid. After treatment with 10 μmol/l SIM luciferase activities were determined. n = 3, *P < 0.05 as indicated. Articles in renal cells SIM-dependent and activation of the ERK/PKA/ CREB/CRE/HO-1 axis has been described. The activated HO-1 protects against oxidative stress in the kidney (31,32) including obesity-associated renal oxidative stress and subsequent renal dysfunction (33) . In our in vitro model, SIM protected renal proximal tubule cells from adverse effects of OA: this protection required activation of HO-1 ( Figure  2) . Since SIM-mediated HO-1 activation is CREB/ERK/PKAdependent (Figures 3 and 4) , protective effects of SIM against OA were also CREB/ERK/PKA-dependent ( Figure 5) .
Based on our data, we propose the following mechanism ( Figure 6 ): SIM activates ERK, which in turn activates CREB but not Nrf2, C/EBP, or jun/fos. The activated CREB binds the CRE in the promoter of the HO-1 gene and activates its transcription. Simultaneously, SIM also activates PKA, whichsimilar to ERK-further activates CREB and hence, the HO-1 promoter. The increased HO-1 then attenuates oleic aciddependent production of ROS and consequent reduced tubular injury (Figure 6) .
Since SIM therapy to treat dyslipidemia in children is approved by the FDA (6), the proposed mechanism may offer therapeutic means beyond lipid lowering to slow obesity-associated kidney injury; that may have profound impact on our state as Mississippi has one of the highest rates of childhood obesity (34) and potentially obesity-associated kidney disease per population in the country. However, further in vivo (mice) studies are needed to ascertain whether the above described in vitro mechanism translates.
METHODS
Cell Lines and Treatment
The rat renal proximal tubule cell line (NRK52E) was purchased from American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum in 5% CO 2 atmosphere. Cells were treated with 100 μmol/l oleic acid (Sigma-Aldrich, ST. Louis, MO) as previously reported (5), 5-100 µmol/l SIM (Sigma-Aldrich), 10 μmol/l tin protoporphyrine (SnPP, Sigma-Aldrich) to inhibit HO-1 activity or 10 μmol/l H89 (Sigma-Aldrich) to inhibit PKA.
In our experiments, we used free-instead of albumin-bound-OA, even though fatty acids present in albumin-bound complexes in vivo (35) . However, dissociation from albumin precedes fatty acid uptake (35) ; thus, intracellular effects of fatty acids are attributed to their free form. Also, this way we could exclude the unwanted effects of albumin toxicity (36) . Our pilot studies confirmed that bovine serum albumin (BSA) itself increases ROS production and ROS production by BSAconjugated OA is higher than free OA itself (Supplementary Figure S1a . n = 3, *P < 0.05 compared to (untreated) control. (c) NRK52E cells were cotransfected with a CRE and renilla luciferase plasmid in the presence or absence of a dnMEK (to inhibit ERK phosphorylation) or 10 μmol/l H89 (to inhibit PKA activation) and treated with 10 μmol/l SIM for 24 h. Luciferase activities were determined as described above. n = 3, *P < 0.05 compared to control, § P < 0.05 compared to SIM treated. (d) NRK52E cells were cotransfected with an HO-1 and renilla luciferase plasmid in the presence or absence of a dnMEK (to inhibit ERK phosphorylation) or 10 μmol/l H89 (to inhibit PKA activation) and treated with 10 μmol/l SIM for 24 h. Luciferase activities were determined as described above. n = 3, *P < 0.05 compared to control, § P < 0.05 compared to SIM treated. 
Measurement of ROS Production
Intracellular generation of ROS was determined by a microplate assay using the oxidant-sensitive 2' ,7'-dichlorofluorescein-diacetate (DCFDA-Invitrogen, Grand Island, NY). Cells grown in 96-well plates were pretreated with SIM as needed then loaded with 100 μmol/l DCFDA in Hank's balanced salt solution for 30 min at 37 °C. After incubation, the dye was washed away with fresh Hank's balanced salt solution and treated with 100 μmol/l OA: increase in fluorescence was monitored in a fluorescence plate reader (Fluorocount, Packard) at 485 nm exc /530 nm em . ROS production was calculated as changes in fluorescence/30 min/0.5 × 10 6 cells and expressed as percentage of untreated values as described elsewhere (37) .
Measurement of Oxidative Stress
Extent of oxidative stress was determined in lysates of cells by measuring the lipid peroxidation adduct 4-HNE using the OxiSelect HNE-His adduct ELISA kit from Cell Biolabs, San Diego, CA. Briefly, cells grown in 96-well plates were treated with 100 μmol/l oleic acid in the presence or absence of the appropriate pharmacologic/genetic inhibitors for 24 h. Values were normalized to protein content of the lysates and expressed as percentage of the control (untreated) cells.
Reporter Luciferase Studies
Cells were transfected with either an HO-1-promoter luciferase (12) , ARE-luc/Renilla (Qiagen, Valencia, CA), CRE-luc (Agilent Technologies, Santa Clara, CA), AP-1-luc (Agilent Technologies), or CCAAT-luc/Renilla (Qiagen) plasmid. The HO-1-luc, CRE-luc and AP1-luc plasmids were also cotransfected with a renilla luciferase (Promega, Madison, WI) using Lipofectamine 3000 as suggested Figure 5 . Protective effects of simvastatin (SIM) depends on extracellular signal regulated kinase, PKA, and CREB activation. (a) NRK52E cells were treated with 100 μmol/l oleic acid (OA) in the presence or absence of 10 μmol/l SIM. Some cells were transfected with either dnMEK or M1CREB or treated with H89 prior to treatment with SIM+OA. Reactive oxygen species production was determined as described in Materials and Methods. Results were expressed as percentage of untreated. n = 3, *P < 0.05 compared to control, § P < 0.05 compared to OA-treated, † P < 0.05 compared to SIM+OA-treated. (b) In a similar setting to (a) extent of oxidative stress (intracellular HNE content) was also determined. Results were expressed as percentage of untreated. n = 3, *P < 0.05 compared to control, § P < 0.05 compared to OA-treated, † P < 0.05 compared to SIM+OA-treated. In addition, cytotoxicity (by means of lactate dehydrogenase (LDH) release and caspase3/7 activation) was also determined (c and d). Results were expressed as percentage of untreated. n = 3, *P < 0.05 compared to control, § P < 0.05 compared to OA-treated, † P < 0.05 compared to SIM+OA-treated. Simultaneously, SIM also activates PKA, which-similar to ERK-further activates CREB and hence, the HO-1 promoter. The increased HO-1 than attenuates oleic acid-dependent production of reactive oxygen species and consequent tubular injury.
